JAMA ophthalmology۲٬۰۲۵متاآنالیزنمایه شده در PubMed
Gabriella R Natividade, Bernardo F Spiazzi, Matheus W Baumgarten, Caroline Bassotto, Afonso A Pereira, Bruna L Fraga, Bruno G Scalco, Nicole R Mattes, Daniel Lavinsky, Caroline K Kramer, Fernando Gerchman
چکیده
Semaglutide is a widely used treatment for diabetes and obesity, offering considerable cardiovascular benefit. However, its association with ocular adverse events remains uncertain. To assess the incidence of eye disorders, diabetic retinopathy, and nonarteritic anterior ischemic optic neuropathy…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1001/jamaophthalmol.2025.2489